292 related articles for article (PubMed ID: 12633677)
1. Liver X receptors and the control of cholesterol homeostasis: potential therapeutic targets for the treatment of atherosclerosis.
Millatt LJ; Bocher V; Fruchart JC; Staels B
Biochim Biophys Acta; 2003 Mar; 1631(2):107-18. PubMed ID: 12633677
[TBL] [Abstract][Full Text] [Related]
2. Liver LXRα expression is crucial for whole body cholesterol homeostasis and reverse cholesterol transport in mice.
Zhang Y; Breevoort SR; Angdisen J; Fu M; Schmidt DR; Holmstrom SR; Kliewer SA; Mangelsdorf DJ; Schulman IG
J Clin Invest; 2012 May; 122(5):1688-99. PubMed ID: 22484817
[TBL] [Abstract][Full Text] [Related]
3. Liver X receptor modulators: effects on lipid metabolism and potential use in the treatment of atherosclerosis.
Fiévet C; Staels B
Biochem Pharmacol; 2009 Apr; 77(8):1316-27. PubMed ID: 19101522
[TBL] [Abstract][Full Text] [Related]
4. LXR agonists for the treatment of atherosclerosis.
Jaye M
Curr Opin Investig Drugs; 2003 Sep; 4(9):1053-8. PubMed ID: 14582448
[TBL] [Abstract][Full Text] [Related]
5. Liver X receptor: a cardinal target for atherosclerosis and beyond.
Parikh M; Patel K; Soni S; Gandhi T
J Atheroscler Thromb; 2014; 21(6):519-31. PubMed ID: 24695022
[TBL] [Abstract][Full Text] [Related]
6. Liver X receptor (LXR)-beta regulation in LXRalpha-deficient mice: implications for therapeutic targeting.
Quinet EM; Savio DA; Halpern AR; Chen L; Schuster GU; Gustafsson JA; Basso MD; Nambi P
Mol Pharmacol; 2006 Oct; 70(4):1340-9. PubMed ID: 16825483
[TBL] [Abstract][Full Text] [Related]
7. Liver X receptors and atherosclerosis.
Lala DS
IDrugs; 2004 Jun; 7(6):563-9. PubMed ID: 15197661
[TBL] [Abstract][Full Text] [Related]
8. Liver X receptors (LXRs). Part I: structure, function, regulation of activity, and role in lipid metabolism.
Wójcicka G; Jamroz-Wiśniewska A; Horoszewicz K; Bełtowski J
Postepy Hig Med Dosw (Online); 2007 Dec; 61():736-59. PubMed ID: 18063918
[TBL] [Abstract][Full Text] [Related]
9. Macrophage liver X receptor is required for antiatherogenic activity of LXR agonists.
Levin N; Bischoff ED; Daige CL; Thomas D; Vu CT; Heyman RA; Tangirala RK; Schulman IG
Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):135-42. PubMed ID: 15539622
[TBL] [Abstract][Full Text] [Related]
10. Different roles of liver X receptor alpha and beta in lipid metabolism: effects of an alpha-selective and a dual agonist in mice deficient in each subtype.
Lund EG; Peterson LB; Adams AD; Lam MH; Burton CA; Chin J; Guo Q; Huang S; Latham M; Lopez JC; Menke JG; Milot DP; Mitnaul LJ; Rex-Rabe SE; Rosa RL; Tian JY; Wright SD; Sparrow CP
Biochem Pharmacol; 2006 Feb; 71(4):453-63. PubMed ID: 16325781
[TBL] [Abstract][Full Text] [Related]
11. Liver X receptors: Xcreting Xol to combat atherosclerosis.
Francis GA; Annicotte JS; Auwerx J
Trends Mol Med; 2002 Oct; 8(10):455-8. PubMed ID: 12383763
[TBL] [Abstract][Full Text] [Related]
12. Liver X receptor in cholesterol metabolism.
Zhao C; Dahlman-Wright K
J Endocrinol; 2010 Mar; 204(3):233-40. PubMed ID: 19837721
[TBL] [Abstract][Full Text] [Related]
13. Biological role of liver X receptors.
Baranowski M
J Physiol Pharmacol; 2008 Dec; 59 Suppl 7():31-55. PubMed ID: 19258656
[TBL] [Abstract][Full Text] [Related]
14. Ligand activation of LXR beta reverses atherosclerosis and cellular cholesterol overload in mice lacking LXR alpha and apoE.
Bradley MN; Hong C; Chen M; Joseph SB; Wilpitz DC; Wang X; Lusis AJ; Collins A; Hseuh WA; Collins JL; Tangirala RK; Tontonoz P
J Clin Invest; 2007 Aug; 117(8):2337-46. PubMed ID: 17657314
[TBL] [Abstract][Full Text] [Related]
15. Hepatic cholesterol metabolism and resistance to dietary cholesterol in LXRbeta-deficient mice.
Alberti S; Schuster G; Parini P; Feltkamp D; Diczfalusy U; Rudling M; Angelin B; Björkhem I; Pettersson S; Gustafsson JA
J Clin Invest; 2001 Mar; 107(5):565-73. PubMed ID: 11238557
[TBL] [Abstract][Full Text] [Related]
16. Activation of LXRs prevents bile acid toxicity and cholestasis in female mice.
Uppal H; Saini SP; Moschetta A; Mu Y; Zhou J; Gong H; Zhai Y; Ren S; Michalopoulos GK; Mangelsdorf DJ; Xie W
Hepatology; 2007 Feb; 45(2):422-32. PubMed ID: 17256725
[TBL] [Abstract][Full Text] [Related]
17. Macrophage-independent regulation of reverse cholesterol transport by liver X receptors.
Breevoort SR; Angdisen J; Schulman IG
Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1650-60. PubMed ID: 24947527
[TBL] [Abstract][Full Text] [Related]
18. Liver X receptors as potential therapeutic targets in atherosclerosis.
Zhu Y; Li Y
Clin Invest Med; 2009 Oct; 32(5):E383-94. PubMed ID: 19796580
[TBL] [Abstract][Full Text] [Related]
19. Nuclear receptors as targets for drug development: regulation of cholesterol and bile acid metabolism by nuclear receptors.
Makishima M
J Pharmacol Sci; 2005 Feb; 97(2):177-83. PubMed ID: 15725701
[TBL] [Abstract][Full Text] [Related]
20. The role of oxysterols in cholesterol homeostasis.
Wolf G
Nutr Rev; 1999 Jun; 57(6):196-8. PubMed ID: 10439633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
